Vynova continues investing: KOH conversion on track, NaOH expansion announced

Vynova Group confirms that the construction of its new state-of-the-art potassium hydroxide (KOH) membrane electrolysis facility in Tessenderlo (Belgium) remains fully on schedule. In addition to the KOH conversion project, Vynova plans to significantly expand the sodium hydroxide (NaOH) capacity at its Tessenderlo site. Both investments reconfirm the company's commitment to the KOH and NaOH markets.

  • KOH conversion at Tessenderlo site on track for completion in Q2 2018
  • Significant expansion of NaOH capacity in Tessenderlo by 2019
  • Continued long-term commitment to KOH and NaOH market

Vynova Group confirms that the construction of its new state-of-the-art potassium hydroxide (KOH) membrane electrolysis facility in Tessenderlo (Belgium) remains fully on schedule. The project is on track for completion in the second quarter of 2018. The new membrane facility will replace the existing mercury cell room.

“Our new world scale facility will enable us to continue as a reliable partner for our customers and ensure our long-term supply of KOH”, says Vynova President Stefan Sommer.

In addition to the KOH conversion project, Vynova plans to significantly expand the sodium hydroxide (NaOH) capacity at its Tessenderlo site. This expansion will also create additional capacity of chlorine (Cl2), which will be used for the production of ethylene dichloride (EDC). Project completion is expected by early 2019.

Both investments reconfirm the commitment of Vynova, an International Chemical Investors Group (ICIG) company, to the KOH and NaOH markets.

ICIG already owns a successfully converted KOH production facility on the site of Potasse et Produits Chimiques SAS (PPC) in Thann (France). “With the KOH conversion in Tessenderlo, we will further strengthen our leading position as the only membrane producer of KOH with two production sites in Europe”, comments Dr. Achim Riemann, Managing Director of ICIG.

About Vynova
Vynova is a leading European PVC and chlor-alkali company. Our products play a key role in manufacturing numerous industrial products and consumer goods that improve our quality of life. With production sites in five countries and 1,200 committed employees, we generate annual sales of nearly 1 billion euros.
Established in 2015, Vynova is the chlor-vinyls platform of the International Chemical Investors Group (ICIG). Our product offering comprises multiple grades of suspension PVC (S-PVC), KOH and other potassium derivatives, caustic soda (NaOH) and sodium hypochlorite (NaOCl).
For more information, visit www.vynova-group.com.

About International Chemical Investors Group (ICIG)
International Chemical Investors Group (ICIG) is a privately owned industrial group with sales in excess of 2 billion euros and more than 6,000 employees worldwide. ICIG is focusing on three main platforms: Pharmaceuticals under the CordenPharma brand, Fine Chemicals under the WeylChem brand and Chlorovinyls under the Vynova brand. Since inception in 2004, ICIG has acquired 26 independent chemicals and pharmaceutical businesses in Europe and the United States, all of which have origins in major global chemical or pharmaceutical corporations.
For more information about International Chemical Investors Group: www.ic-investors.com.

Contact:
Yannick Brusselmans
Group Communication Manager
Phone: +32 479 32 34 99
Email: yannick.brusselmans@vynova-group.com  

PRESS RELEASES

Discover our latest press releases or contact our communication department for more information.

We are happy to answer your media enquiries quickly and directly.

CONTACT

Yannick Brusselmans
Group Communication Manager
+32 479 32 34 99

EMAIL

Yannick Brusselmans